Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 3, 2020

Primary Completion Date

December 18, 2023

Study Completion Date

December 13, 2024

Conditions
Charcot-Marie-Tooth Type 1A Neuropathy
Interventions
DIAGNOSTIC_TEST

Exploratory physiopathology study, including non-invasive functional explorations carried out in patients with Charcot-Marie-Tooth disease type 1A

The data of the gait analysis, posturography and strength analyses as well as the questionnaires' scores will be taken into account in this research. At 6 months and at 1 year, occurrence of a fall will be recorded in order to prospectively monitor this parameter. A final analysis will be carried out at 1 year from the first according to the same methods as the initial assessment.

Trial Locations (1)

63000

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT05142059 - Fall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go Test | Biotech Hunter | Biotech Hunter